drugset / Trial / NCT00822692

Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection

NCT00822692

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients will be enrolled in a multi-center study (Wilford Hall Medical Center and Brooke Army Medical Center) to prospectively evaluate outcome after treatment for an uncomplicated skin abscess.

Timeline

Start
2008-07
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sulfamethoxazole Small molecule 160 mg Oral
Comparator Trimethoprim Small molecule 800 mg Oral